Apollo’s ₹477 Cr profit pulse — is India’s healthcare boom just beginning?

🏥 Q2 FY2026 Financial Highlights - Net Profit: ₹477 crore, up 26% YoY - Revenue: ₹6,304 crore, up 13% YoY - EBITDA: ₹941 crore, up 15.46% YoY; margin expanded to 14.9% - ARPOB (Average Revenue Per Occupied Bed): ₹1,73,318, up 9% YoY - Healthcare Services Revenue: ₹3,217 crore — largest segment contributor 🔍 Key Strategic Developments - Hospital Expansion: - New 500-bed hospital planned in Worli, Mumbai - Lucknow facility expanding from 300 to 500 beds - Total 3,512 beds to be added across 11 locations over 4 years - Digital Health Push: Apollo 24/7 platform continues scaling teleconsultation and diagnostics - Operational Efficiency: Improved occupancy and ARPOB reflect strong execution ⚠️ Investor Watchouts - Seasonal Fluctuations: Q2 typically benefits from post-monsoon demand; watch Q3 normalization - Geopolitical Risks: Global supply chain and pharma input costs may impact margins - Capex Intensity: Aggressive expansion could pressure short-term cash flows 🚀 Future Growth Outlook - Tier-2 & Tier-3 Penetration: New hospitals in underserved regions to drive volume - Preventive & Wellness Services: Rising demand for diagnostics and chronic care management - Digital Integration: AI-driven triage, remote monitoring, and e-pharmacy growth - Brand Strength: Apollo remains India’s most trusted private healthcare brand